|
|
||||||||
Institute for Environmental Medicine, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6068
| |
ABSTRACT |
|---|
|
|
|---|
The current study examined whether long-term culture of macrophages affects their metabolism of surfactant components. Compared with freshly isolated resting macrophages in culture for 1 h, macrophages attached to plastic dishes for 24 h showed evidence of conversion to a "primed" state with 1) an altered morphology characterized by a larger size, ruffled membranes, lamellipodia, and a "foamy" appearance after attachment to glass and 2) a fivefold greater respiratory burst in response to phorbol 12-myristate 13-acetate stimulation. On incubation with iodinated surfactant protein A (SP-A), the 24-h alveolar or tissue macrophages showed a 5- or a 23-fold greater increase in SP-A degradation, respectively, than macrophages cultured for 1 h. Conditioned media experiments demonstrated that the elevated rate of SP-A degradation after prolonged culture was not a result of proteases secreted by the macrophages. Incubation of cells with NH4Cl reduced the degradation of SP-A to a similar extent (to 33% of control values) in resting and primed tissue macrophages. On the other hand, length of time of cell culture did not affect macrophage uptake and degradation of [3H]dipalmitoylphosphatidylcholine in mixed unilamellar liposomes. Thus freshly isolated resting tissue and alveolar macrophages can be primed to specifically increase their rate of SP-A degradation. Activation of macrophages associated with lung disease may be important for SP-A metabolism and surfactant function.
lung; human alveolar proteinosis; reduced oxygen species; phospholipid; pulmonary surfactant
| |
INTRODUCTION |
|---|
|
|
|---|
THE ALVEOLAR MACROPHAGE is important in maintaining the ability of the lung to preserve sterility and to respond to injury. These macrophages are derived ultimately from peripheral blood monocytes that have been recruited into the lung tissue by chemoattractants. Once in the lung, cytokines promote their maturation into interstitial macrophages, which can then move into the alveolar space in response to appropriate signals (for review see Ref. 25). Alveolar macrophages release a variety of products, including cytokines, enzymes, biologically active lipids, and oxygen metabolites, and have >50 ligand-specific membrane receptors on the cell surface (for review see Ref. 41).
In addition to host defense, evidence is accumulating that alveolar macrophages also play an important role in the turnover of surfactant through uptake and degradation of surfactant components. In vivo studies have documented the presence of tubular myelin figures and surfactant protein A (SP-A) within macrophages lining the alveolar space (36, 45). In vitro studies have demonstrated the ability of alveolar macrophages isolated by lung lavage to degrade phospholipid (32, 48), surfactant protein B (5), and SP-A (6, 48). Macrophage surface receptors specific for SP-A have been described (14, 37, 38) and recently isolated (13). Because SP-A has been shown to modulate phospholipid uptake (4, 43, 47), secretion (18, 40), and catabolism (21) by type II cells, macrophage degradation of SP-A may contribute to the regulation of surfactant levels in the alveoli.
On injury to the lung, the inflammatory cell population of the lung increases (3) and surfactant components are altered (16). Although alveolar macrophages provide the first line of defense in the lower airways, when the system is overwhelmed, materials may pass through a damaged epithelial barrier into the interstitium, where they may be engulfed by interstitial macrophages (for review see Ref. 10). Pulmonary macrophage appearance can be dramatically changed from small, round cells to large "foamy" cells, depending on the etiology of lung damage (44). Such morphological changes may reflect alterations in cell biochemistry that would affect the metabolism of surfactant by these primed or "activated" macrophages and provide a possible mechanism whereby changes in surfactant levels occur. To convert a nonresponsive macrophage to a responsive or "primed" state in vivo, macrophages are elicited by injection of thyoglycollate or endotoxin (26). In vitro, adherence of human macrophages to protein-coated surfaces primed the macrophages for a massive respiratory burst on exposure to cytokines (35), whereas macrophages adhered to plastic produced less reactive oxygen species (ROS). Thus resting and primed macrophages can be activated on stimulation, but the degree of responses differs quantitatively. We noted that alveolar and tissue macrophages markedly altered their morphological appearance after 24 h of attachment to a culture dish and centrifugation onto glass slides. The cells became large and vacuolated with many pseudopodia, physical characteristics of active macrophages. We compared freshly isolated resting macrophages with 24-h macrophages to determine whether priming by this mechanism alters the uptake and degradation of surfactant components.
| |
METHODS |
|---|
|
|
|---|
Lung cell preparation and staining.
Alveolar macrophages were isolated from pathogen-free male
Sprague-Dawley rats (500 g) by lung lavage, as described previously (5). The alveolar macrophages (4 × 106) were plated in 35-mm
plastic dishes (Costar, Cambridge, MA) for 1 h at 37°C in minimal
essential medium (MEM) with 10% fetal calf serum (FCS). After 1 h, the
cells were washed three or more times to remove red blood cells and
other nonadherent cells. Ninety-nine percent of the adherent cells were
alveolar macrophages (5). The cells were then used for study or
refed MEM containing 10% FCS and were examined 24 h later.
Interstitial macrophages were isolated from minced rat lungs. The lungs
were perfused, lavaged eight times with 7 ml of calcium-free
phosphate-buffered saline containing 10 mM
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, 0.2 mM ethylene glycol-bis(
-aminoethyl
ether)-N,N,N',N'-tetraacetic acid, and 6 mM glucose, minced with a tissue chopper, shaken in a
37°C water bath for 3 min, filtered through nylon mesh, and centrifuged (7). The tissue macrophages (4 × 106) attached to 35-mm plastic
dishes (Costar) after 1 h of incubation at 37°C in MEM with 10%
FCS. The plates then were washed at least three times to remove
nonadherent cells, including red blood cells. The resultant preparation
contained <15% nonmacrophage cell types, with lymphocytes as the
principal contaminating cell. The cells were studied immediately or
refed MEM containing 10% FCS and were studied 24 h later. After 24 h,
~75% of the alveolar and tissue macrophages had detached from the
plastic, and these cells then were washed off the dishes. Only
macrophages that remained attached to the dishes were used in
experiments, and the viability of these cells was >98% by vital dye
exclusion. For light-microscopic examination, the macrophages were
scraped from the dish, attached to a glass slide using a cytospin
(Shandon, Pittsburgh, PA), stained using a Kwik-Diff stain kit and
visualized by microscopy under oil.
Surfactant and SP-A isolation. Bronchoalveolar lavage fluid was obtained from normal (slaughterhouse) bovine lungs or patients with alveolar proteinosis. Surfactant was isolated from an NaCl-NaBr gradient after centrifugation (20). The bovine and human SP-A were purified from surfactant according to the butanol extraction method described by Hawgood et al. (24). SP-A was iodinated using Iodo-gen (Pierce, Rockford, IL), as described previously (6), and was dialyzed against tris(hydroxymethyl)aminomethane-buffered saline to remove free Na125I. An aliquot of 125I-SP-A was analyzed for protein concentration and trichloroacetic acid (TCA) precipitability. The specific activity of the radioiodinated SP-A preparations was 200-2,000 cpm/ng protein, and 97% of the labeled SP-A was precipitable with TCA. The ligand was stored and used within 2 wk of iodination.
The purity of the SP-A preparation was monitored using sodium dodecyl sulfate-polyacrylamide gel electrophoresis according to the method of Laemmli (27), as described previously (6). Autoradiographic analysis of radiolabeled 125I-SP-A showed no evidence of degradation products or contaminating proteins. Iodinated SP-A was added to surfactant with gentle mixing and placed on ice for 30 min before use. The 125I-labeled bovine SP-A was reconstituted with surfactant at a labeled protein-to-surfactant phospholipid ratio of 1:100 and a labeled SP-A protein-to-unlabeled SP-A protein in surfactant ratio of 1:17, assuming that the amount of SP-A in bovine surfactant was 40% of total protein (6).Interaction of SP-A with cells. Cells were incubated with radiolabeled SP-A for the indicated time period at 37°C. To terminate the experiment, the medium was removed and processed as outlined below. The cells were washed three times with MEM and twice with phosphate-buffered saline to remove unbound ligand. The cells were then dissolved in 0.2 N NaOH (total cell-associated SP-A). Aliquots were taken to measure radioactivity and protein (30).
The medium from the experiment was centrifuged to remove any cells and precipitated with cold 10% TCA. Insulin was added to serve as a carrier protein. The intact precipitated protein was removed by centrifugation, and the supernatant was treated with KI and H2O2 and was extracted with chloroform to remove any free labeled iodide, as described previously (6). An aliquot of the aqueous fraction of the 125I-labeled TCA-soluble, chloroform-extracted supernatant containing 125I-labeled amino acids and/or small protein fragments was counted (5, 23). This material represents SP-A degradation products released from the cell into the culture media (23), as outlined in detail previously (5). SP-A protein association or degradation by the cells was calculated from the radioactivity and protein in the cell extract and the specific activity of the SP-A. Medium with 125I-SP-A was incubated on empty dishes in each experiment, and any 125I counts were subtracted from the radioactivity found in the presence of cells. Radioactive iodine counts from empty dishes found in the NaOH were <10%, and those in the media as degradation products were <20%. Separate dishes of cells were used to determine the amount of cellular protein per dish present at the initiation of each experiment and served as the denominator in the quantitation of the amount of SP-A degraded per milligram of protein, since experimental manipulations caused detachment of a fraction of the cells. Because of the variation in cellular metabolism between experiments, the extent of cell association and degradation (as ng SP-A/mg cell protein) at a specified concentration of SP-A or time of experiment was set equal to 100% (control) and the remaining data were expressed as a percentage of control. This allowed comparison of data from several experiments. For conditioned media experiments, macrophages were incubated with medium for 2 h, the medium was centrifuged to remove detached cells, and the conditioned medium was transferred to empty plastic dishes (35 mm; Costar). Fresh medium was added to the macrophages and to other empty dishes. 125I-labeled bovine SP-A (8.6 µg/ml in surfactant) was added to all dishes, and the cells were incubated for 2 h. Then the medium was removed and assayed for SP-A degradation products. Degradation that occurred with fresh medium on empty dishes was subtracted from the data.Measurement of ROS production. ROS generation was followed using the fluorescent detection of dichlorofluorescein (DCF), formed by the oxidation of the nonfluorescent precursor DCF (DCFH) according to the method described by Cathcart et al. (11). 2',7'-Dichlorofluorescin diacetate (1 mM; Eastman Kodak, Rochester, NY) in ethanol was hydrolyzed to DCFH with 0.01 N NaOH at room temperature for 30 min and neutralized by a 1:40 dilution in Krebs-Ringer buffer. Macrophages were incubated for 20 min in 2 ml of Krebs-Ringer buffer containing 5 µM DCFH, 12.5 µg/ml horseradish peroxidase (Sigma Chemical, St. Louis, MO), and 1 mM glucose with or without PMA at 50 ng/ml. DCF fluorescence was measured on a Hitachi fluorescence spectrophotometer using the excitation and emission wavelengths of 490 and 530 nm, respectively. By use of H2O2 as a standard, the assay was linear from 100 nM to 1 µM H2O2. The rate of ROS formation was continuously measured over a 20-min period by analysis of 0.3 ml of media taken at several time points. The rate of ROS production was calculated from the linear portin of the curves following the initial lag phase and was expressed in arbitrary fluorescence units.
Preparation of liposomes.
Lipids were obtained from Avanti (Birmingham, AL), and tracer
radiolabeled
[3H-methyl]choline
dipalmitoylphosphatidylcholine (DPPC) was from New England Nuclear. The
liposomes were composed of a mixture of lipids combined in the ratio of
0.5 mol of DPPC, 0.25 mol of egg phosphatidylcholine (PC), 0.15 mol of
cholesterol, and 0.1 mol of egg phosphatidylglycerol and tracer
[3H]DPPC (specific
activity = 4,400 degradations · min
1 · nmol
1).
The lipids were dried under nitrogen and were resuspended in buffer.
Liposomes were prepared by extrusion through polycarbonate membranes,
as previously described (19), and were stored overnight at 4°C.
Uptake and degradation of DPPC by macrophages. Macrophages were incubated with [3H]DPPC-labeled liposomes at 80 µM DPPC (120 µM total PC) for 2 h at 37°C. Cells then were washed three times with MEM, harvested with trypsin (0.05% trypsin in 0.02% EDTA), and pelleted twice by centrifugation. Aliquots were taken for protein, total degradations per minute by scintillation counting, and lipid extraction using the method of Bligh and Dyer (8). The aqueous fraction was analyzed for degradations per minute. One aliquot of the lipid fraction was subjected to thin-layer chromatography on silica gel G plates run in the solvent system CHCl3-CH3OH-NH4OH-H2O (65:35:2.5:2.5 by volume) to separate lysophosphatidylcholine from PC (19, 33). The bands were identified by exposure to I2 vapor, scraped, and counted for degradations per minute. Another aliquot of the lipid fraction was osmicated and chromatographed on neutral alumina columns to isolate disaturated PC (31). Incorporation into the different fractions was calculated on the basis of the specific activity of DPPC. Unsaturated PC was determined by subtraction of DPPC from total PC (19).
Statistical analysis. Values are means of at least two samples in each experiment and are presented as means ± SE for the number of experiments indicated (n) or means ± range when the number of experiments was two. Each experiment used a different preparation of macrophages. Statistical analysis was performed using the t-test with SigmaStat for Windows (Jandel, San Rafael, CA), where significance is set at P < 0.05. When SE bars are not visible on Figs. 2 and 3, they are within the symbols.
| |
RESULTS |
|---|
|
|
|---|
Light microscopy. Alveolar and tissue macrophages cultured for 1 or 24 h were cytospun onto glass slides, and stained preparations were visualized by light microscopy (Fig. 1). Most of the 1-h alveolar and tissue macrophages (Fig. 1, A and B) were circular, compact cells with darkly staining nuclei, distinct smooth plasma membranes, and few pseudopodia. On the other hand, most of the 24-h macrophages (Fig. 1, C and D) showed morphological indications of activation, such as an enlargement of the cytoplasmic area with many filopodia or lamellipodia, or a vacuolated appearance with a large, irregular, flattened shape and pale nuclei.
|
ROS release. One measure of the responsive state of macrophages is an increased rate of release of superoxide and H2O2 in primed cells compared with quiescent cells when challenged with PMA (26). To examine whether the 24-h macrophages were "primed," the freshly isolated alveolar macrophages (1-h cells) or the macrophages cultured overnight (24-h cells) were incubated without or with PMA (50 ng/ml) in the presence of 5 µM DCFH. The 1-h macrophages showed a low rate of ROS production that was stimulated over threefold by the addition of PMA (Table 1). Incubation of the 24-h macrophages with PMA resulted in a sevenfold increase in ROS production, which was significantly (5-fold) higher than that found after PMA exposure of 1-h macrophages. Similar results were seen with tissue macrophages, although the production of ROS was attenuated compared with the alveolar macrophages. PMA stimulation of the tissue macrophages resulted in a significant enhancement of ROS levels by the 24-h macrophages (2-fold) over that produced by 1-h macrophages.
|
SP-A metabolism. The cell association and degradation of SP-A by alveolar macrophages either freshly isolated (1 h) or in culture for 24 h are shown in Fig. 2. Cells were incubated for 3 h at 37°C with increasing concentrations of 125I-SP-A. The media then were removed and assayed for SP-A degradation products. The cells were harvested by dissolution in 0.2 N NaOH to determine the total SP-A associated with the cell, which includes the SP-A bound to the surface of the cell and that internalized into the cell during the 3-h incubation period. The extent of SP-A cell association and degradation for the 1- and 24-h macrophages varied with the SP-A concentration in the medium, as has been reported previously for binding of SP-A to freshly isolated alveolar macrophages (38). Cell association of SP-A, binding plus uptake, was similar for 1- and 24-h alveolar macrophages, whereas degradation of SP-A was significantly enhanced approximately fivefold with overnight culture for all concentrations of SP-A tested. For tissue macrophages (Fig. 3), the cell association of SP-A by the 24-h macrophages was similar to that of freshly isolated cells. However, there was a striking 20-fold increase in the amount of SP-A degradation by tissue macrophages cultured for 24 h compared with macrophages in culture for 1 h.
|
|
|
|
Phospholipid metabolism. Although the 24-h macrophages demonstrated an enhanced SP-A degradation, the phospholipid metabolism by these cells was not affected by time in culture. Macrophages were incubated for 2 h with liposomes containing [3H]DPPC, and the uptake and degradation of the DPPC were evaluated (Table 4). The incorporation of DPPC by alveolar and tissue macrophages was similar and was unaffected by time in culture. The macrophages degraded approximately one-half of the internalized DPPC during a 2-h incubation regardless of the source of macrophages or the time in culture. The principal radiolabeled metabolites of choline-labeled DPPC were recovered in the aqueous soluble portion with a small fraction in lysophosphatidylcholine (Table 5). There were virtually no 3H-labeled unsaturated phospholipids in the cells, indicating that the macrophages did not reutilize the [3H]choline for unsaturated PC synthesis, unlike the findings with type II pneumocytes (19). After 2 h, the incubation media contained <0.5% of radioactivity in the aqueous soluble choline-containing products.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Alveolar macrophages freshly isolated from the lung by lavage have demonstrated the ability to bind, incorporate, and degrade SP-A (6, 37, 38, 48). The present study demonstrates that alveolar and tissue macrophages that have been in culture for 24 h have characteristics of primed macrophages with altered morphology and enhanced respiratory burst on stimulation. Furthermore, the 24-h macrophages show a substantially elevated rate of SP-A degradation compared with the fresh macrophages because of intracellular degradation of SP-A. On the other hand, macrophage uptake and degradation of phospholipid liposomes were not altered by prolonged culture time, showing differential regulation of catabolic function.
Pulmonary macrophages are distinguished primarily by their anatomic location in the lung. The alveolar macrophage is found on the surface of the alveoli in contact with the epithelial cells lining the airway and can be isolated by lavage of the alveolar compartment. The interstitial macrophage resides within the lung parenchyma, where it undergoes maturation and differentiation before migrating into the alveoli and becoming the alveolar macrophage. The interstitial macrophage is isolated by mechanical disruption of lavaged lung with or without enzymatic digestion of lung slices. It remains controversial as to whether the postlavage tissue macrophages represent subpopulations of alveolar macrophages or are, in fact, interstitial macrophages analogous to those of other organs because of the lack of distinguishing characteristics between the two cell types. The alveolar and interstitial macrophages share most of the same functional properties of phagocytic activity (28) and fibroblast growth factor production (1), although they exhibit quantitative differences in some functions, such as cytokine and oxygen radical production (29). In the present study, macrophages isolated from lung minced tissue without enzymatic digestion after extensive lung lavage are referred to as tissue macrophages. Quantitative but not qualitative differences in SP-A metabolism and ROS production were noted between the tissue and alveolar macrophages that would indicate that they were different cell types or were at a different stage of maturation. Freshly isolated alveolar macrophages took up slightly more SP-A than tissue macrophages, whereas alveolar macrophages degraded two to three times as much SP-A. Although both types of pulmonary macrophages increased their rates of SP-A degradation after activation by prolonged time in culture, tissue macrophages demonstrated a greater change with time in culture (23-fold) than the alveolar macrophages (5-fold). On the other hand, ROS production stimulated by PMA was higher in alveolar than in tissue macrophages. However, the phospholipid metabolism of the pulmonary macrophages was quite similar, as reflected in the rates of uptake and degradation of DPPC.
Macrophages are usually studied as freshly isolated cells in suspension
or allowed to attach to a dish for a short period of time. The priming
of pulmonary macrophages by prolonged culture has not been reported
directly, although Prokhorova et al. (39) noted a greater sensitivity
to lipopolysaccharide and interferon-
stimulation of nitric oxide
production after overnight culture of interstitial macrophages than in
freshly isolated cells, data that would be consistent with an increase
in reactive state. In addition, a 24-h exposure of macrophages to serum
proteins causes rabbit alveolar macrophages to release reactive oxygen
intermediates (22), induces maturation of human monocytes as assessed
by increases in intracellular enzymatic activity (34), and stimulates
peritoneal macrophage spreading (9). Primed and activated macrophages demonstrate a greater rate of cell metabolism than resting cells, as
exemplified by a more rapid spreading on glass, higher glucose oxidation, more effective killing of microorganisms, and elevated content of lysosomal enzymes (42). In this study, we have shown that
alveolar and tissue macrophages show morphological and biochemical evidence of priming when placed in tissue culture overnight on plastic
dishes. After 24 h in culture and centrifugation onto glass slides, the
cells were spread, contained empty vacuoles resulting in a foamy
appearance, and had many pseudopodia. In addition, on stimulation with
phorbol ester, the macrophages released elevated amounts of reactive
oxygen species.
The mechanism for macrophage priming by overnight culture is not known. Because only a portion of the cells remain attached to the dishes after 24 h of culture, it is possible that the culture conditions select for cells primed during the 1-h incubation and that 24 h of culture are not necessary to convert the cells to a more responsive state. Another possibility is that the macrophages during 24 h of culture act as frustrated phagocytes, in that they try to "ingest" the tissue culture dish, which they recognize as foreign material. Several pieces of evidence support the conclusion that prolonged culture is priming the cells, and that, rather than selection, is responsible for their increased activity. Light microscopy indicated that the 24-h macrophages, particularly the alveolar macrophages, have a morphology entirely different from that of the 1-h cells and were typified by enlarged, foamy cells with many lamellipodia. Second, a 75% loss of macrophages from the 1-h cell population during 24 h of culture could potentially result in a fourfold increase in catabolism of SP-A on a per milligram of cell protein basis, assuming that all the lost cells were nonresponsive. Although this is close to the 5-fold increase observed for alveolar macrophages, it could not account for the 10- to 23-fold increase in degradation seen with the tissue macrophages. Finally, the data on the production of ROS provide additional evidence that priming of the cells has occurred during 24 h of culture. If the macrophage population at 1 h contained one-fourth primed cells (equivalent to the 24-h cells) and three-fourths resting cells, then PMA stimulation should have increased ROS production 7.3-fold for 1-h macrophages, which is equivalent to 24-h macrophages. However, the 1-h cells were stimulated only 3.8-fold by PMA exposure.
Prolonged culture of macrophages did not substantially affect the cell association of SP-A but markedly enhanced the degradation of SP-A. The fact that binding plus uptake was not altered suggests that the substrate for the degradative enzymes did not change, and thus the catabolic activity must have increased. Because the results are expressed on a "per milligram of cell protein" basis, the increase in cell size means an increase in enzymatic activity per cell. Such a rise in catabolic activity could occur through several mechanisms, including an increase in enzymatic activity, a change in kinetic properties of degradative enzymes, an augmentation in the amount of enzyme, a change in the type of enzymes, or an alteration in intracellular compartmentation. Activated macrophages have been shown to have enhanced antimicrobial activity (2) and an elevation in the content of lysosomal enzymes (for review see Ref. 41). An enrichment in the level of degradative enzymes would be consistent with the enhanced ability to degrade SP-A shown in our data. The increase in degradative ability required prolonged time in culture, since activation of alveolar macrophages with PMA for 3 h served to reduce, not enhance, SP-A degradation.
Our previous studies using freshly isolated alveolar macrophages (6) indicated that the degradation of SP-A occurred within the cell. The present work determined that this was the case regardless of the state of activation. When the pH within intracellular acidic organelles was raised with a lysosomotropic weak base, breakdown of SP-A was inhibited in all the macrophage populations, supporting an important role for such sites in SP-A degradation by pulmonary macrophages. Furthermore, as the external concentration of SP-A was raised, the extent of SP-A degradation was parallel to the increase in cell association of SP-A, demonstrating the dependence of degradation on the amount of cell-associated substrate. Finally, extracellular enzymes that may have been released by primed macrophages (41) did not participate in SP-A catabolism, since medium conditioned by 24-h macrophages did not degrade SP-A.
It was of interest that, whereas SP-A degradation was markedly altered with time in culture, phospholipid degradation was not affected. Such data imply that, once internalized, degradation of surfactant phospholipid and proteins occurs in separate cellular compartments or that only one set of degradative enzymes was activated. Segregation of DPPC and SP-A after uptake has been noted in the isolated, perfused lung (20) and in morphological (48) and biochemical studies (42) of isolated type II cells. The metabolism of DPPC liposomes by macrophages shares some but not all characteristics of type II cells. Table 6 compares the uptake, reutilization, and degradation of phospholipid liposomes by the two cell types. Whereas type II cells incorporated two times as much PC as macrophages, both cell types actively degraded the phospholipid. Sixty-five percent of the PC incorporated into type II cells was recovered as aqueous degradation products, lysophosphatidylcholine, or unsaturated PC, whereas macrophages degraded 50%. Consistent with the expected low rate of macrophage PC synthesis, there was no evidence of reutilization of the liberated [3H]choline by macrophages, whereas type II cells readily resynthesize unsaturated PC from the choline initially associated with the DPPC. The 20% choline "reutilization" by the type II cells shown in Table 6 represents a lower limit, since it does not include choline reincorporated into DPPC.
|
In conclusion, we have shown that freshly isolated interstitial and alveolar macrophages were converted to a responsive state during prolonged culture. These macrophages produced ROS and degraded SP-A, but not phospholipid, at an elevated rate. In several pathophysiological states, including acute endotoxemia, pulmonary interstitial and alveolar macrophages demonstrate enhanced phagocytosis and production of reactive oxygen intermediates (45) and could be more active in their metabolism of SP-A. Although possible effects of various pulmonary diseases on the rate of surfactant lipid and protein turnover by macrophages in intact tissue remain to be determined, the present study demonstrates that the capacity of pulmonary macrophages to degrade SP-A depends on their state of activation.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Dr. Qiping Chen for the iodination of the SP-A, to Dr. Michael Beers for the donation of lavage fluid from patients with alveolar proteinosis, and to Dr. Henry Shuman and Kathy Notarfrancesco for light microscopy and photography.
| |
FOOTNOTES |
|---|
This research was supported by National Heart, Lung, and Blood Institute Grant HL-19737.
Address for reprint requests: S. R. Bates, Institute for Environmental Medicine, University of Pennsylvania, 36th and Hamilton Walk, 1 John Morgan Bldg., Philadelphia, PA 19104.
Received 15 October 1996; accepted in final form 10 June 1997.
| |
REFERENCES |
|---|
|
|
|---|
1.
Adamson, I. Y. R.,
H. L. Letourneau,
and
D. H. Bowden.
Comparison of alveolar and interstitial macrophages in fibroblast stimulation after silica and long or short asbestos.
Lab. Invest.
64:
339-344,
1991[Medline].
2.
Ando, M.,
M. Suga,
K. Shima,
M. Sugimoto,
and
H. Tokuomi.
Activation of alveolar macrophages exposed to lavage-procured immunoglobulin G obtained from normal rabbit lungs.
Infect. Immun.
20:
476-484,
1978
3.
Aso, Y.,
K. Yoneda,
and
Y. Kikkawa.
Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice.
Lab. Invest.
35:
558-568,
1976[Medline].
4.
Bates, S. R.,
C. Dodia,
and
A. B. Fisher.
Surfactant protein A regulates uptake of pulmonary surfactant by lung type II cells on microporous membranes.
Am. J. Physiol.
267 (Lung Cell. Mol. Physiol. 11):
L753-L760,
1994
5.
Bates, S. R.,
and
A. B. Fisher.
Degradation of surfactant protein B by alveolar type II cells.
Am. J. Physiol.
265 (Lung Cell. Mol. Physiol. 9):
L448-L455,
1993
6.
Bates, S. R.,
and
A. B. Fisher.
Surfactant protein A is degraded by alveolar macrophages.
Am. J. Physiol.
271 (Lung Cell. Mol. Physiol. 15):
L258-L266,
1996
7.
Berman, H.,
A. B. Fisher,
and
B. Storey.
Oxidation of sn-glycerol-3-phosphate and acetyl L-carnitine by rat and rabbit alveolar macrophages.
J. Reticuloendothel. Soc.
26:
249-258,
1979[Medline].
8.
Bligh, E. G.,
and
W. J. Dyer.
A rapid method of total lipid extraction and purification.
Can. J. Biochem. Physiol.
37:
911-917,
1959.
9.
Bianco, C.,
A. Eden,
and
Z. A. Cohn.
The induction of macrophage spreading: role of coagulation factors and the complement system.
J. Exp. Med.
144:
1513-1524,
1976.
10.
Bowden, D. H.
Macrophages, dust, and pulmonary diseases.
Exp. Lung Res.
12:
89-107,
1987[Medline].
11.
Cathcart, R.,
E. Schweirs,
and
B. N. Ames.
Detection of picomole levels of hydroperoxide using a fluorescent dichlorofluorescein assay.
Anal. Biochem.
134:
111-116,
1983[Medline].
12.
Chinoy, M. R.,
C. Dodia,
and
A. B. Fisher.
Increased surfactant internalization by rat type II cells cultured on microporous membranes.
Am. J. Physiol.
264 (Lung Cell. Mol. Physiol. 8):
L300-L307,
1993
13.
Chroneos, Z.,
R. Abdolrasulnia,
J. A. Whitsett,
W. R. Rice,
and
V. L. Shepherd.
Purification of a cell-surface receptor for surfactant protein A.
J. Biol. Chem.
271:
16375-16383,
1996
14.
Chroneos, Z.,
and
V. L. Shepherd.
Differential regulation of the mannose and SP-A receptors on macrophages.
Am. J. Physiol.
269 (Lung Cell. Mol. Physiol. 13):
L721-L726,
1995
15.
Coonrod, J. D.
Role of leukocytes in lung defenses.
Respiration
55:
9-13,
1989.
16.
Dethloff, L. A.,
L. B. Gilmore,
A. R. Brody,
and
G. E. R. Hook.
Induction of intra- and extra-cellular phospholipids in the lungs of rats exposed to silica.
Biochem. J.
233:
111-118,
1986[Medline].
17.
Dethloff, L. A.,
and
B. E. Lehnert.
Pulmonary interstitial macrophages: isolation and flow cytometric comparisons with alveolar macrophages and blood monocytes.
J. Leukoc. Biol.
43:
80-90,
1988[Abstract].
18.
Dobbs, L. G.,
J. R. Wright,
S. Hawgood,
R. Gonzales,
K. Venstrom,
and
J. Nellenbogen.
Pulmonary surfactant and its components inhibit secretion of phosphatidylcholine from cultured rat alveolar type II cells.
Proc. Natl. Acad. Sci. USA
84:
1010-1014,
1987
19.
Fisher, A. B.,
and
C. Dodia.
Role of phospholipase A2 enzymes in degradation of dipalmitoylphosphatidylcholine by granular pneumocytes.
J. Lipid Res.
37:
1057-1064,
1996[Abstract].
20.
Fisher, A. B.,
C. Dodia,
and
A. Chander.
Alveolar uptake of lipid and protein components of surfactant.
Am. J. Physiol.
261 (Lung Cell. Mol. Physiol. 5):
L334-L340,
1991
21.
Fisher, A. B.,
C. Dodia,
and
A. Chander.
Inhibition of lung calcium-independent phospholipase A2 by surfactant protein A.
Am. J. Physiol.
267 (Lung Cell. Mol. Physiol. 11):
L335-L341,
1994
22.
Gerberick, G. F.,
J. B. Willoughby,
and
W. F. Willoughby.
Serum factor requirement for reactive oxygen intermediate release by rabbit alveolar macrophages.
J. Exp. Med.
161:
392-408,
1985
23.
Goldstein, J. L.,
and
M. S. Brown.
Binding and degradation of low density lipoproteins by cultured human fibroblasts.
J. Biol. Chem.
249:
5153-5162,
1974
24.
Hawgood, S.,
B. J. Benson,
and
R. L. Hamilton, Jr.
Effects of surfactant-associated proteins and calcium ions on the structure and surface activity of lung surfactant lipids.
Biochemistry
24:
184-190,
1985[Medline].
25.
Holian, A.,
and
R. K. Sheule.
Alveolar macrophage biology.
Hosp. Pract. (Off. Ed.)
25:
53-62,
1990[Medline].
26.
Johnston, R. B.,
C. A. Godzik,
and
Z. A. Cohn.
Increased superoxide anion production by immunologically activated and chemically elicited macrophages.
J. Exp. Med.
148:
115-127,
1978
27.
Laemmli, U. K.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:
680-685,
1970[Medline].
28.
Lehnert, B. E.,
Y. E. Valdez,
and
L. M. Holland.
Pulmonary macrophages: alveolar and interstitial populations.
Exp. Lung Res.
9:
177-190,
1985[Medline].
29.
Lohmann-Matthes, M.-L.,
C. Steinmuller,
and
G. Franke-Ullmann.
Pulmonary macrophages.
Eur. Respir. J.
7:
1678-1689,
1994[Abstract].
30.
Lowry, O. H.,
N. J. Rosenbrough,
L. A. Garr,
and
R. J. Randall.
Protein measurement with Folin-phenol reagent.
J. Biol. Chem.
193:
265-275,
1951
31.
Mason, R. J.,
J. Nellenbogen,
and
J. A. Clements.
Isolation of disaturated phosphatidylcholine with osmium tetroxide.
J. Lipid Res.
17:
281-284,
1976[Abstract].
32.
Miles, P. R.,
V. Castranova,
and
L. Bowman.
Catabolism of rat surfactant disaturated phosphatidylcholines during incubation of alveolar macrophages.
J. Appl. Physiol.
64:
2474-2481,
1988
33.
Mitnick, M. A.,
B. DeMarco,
and
J. M. Gibbons.
Amniotic fluid phosphatidylglycerol and phosphatidylinositol separated by stepwise development thin-layer chromatography.
Clin. Chem.
26:
227-281,
1980
34.
Musson, R. A.
Human serum induces maturation of human monocytes in vitro. Changes in cytolytic activity, intracellular lysosomal enzymes, and nonspecific esterase activity.
Am. J. Pathol.
111:
331-340,
1983[Abstract].
35.
Nathan, C.
Neutrophil activation on biological surfaces.
J. Clin. Invest.
80:
1550-1560,
1987.
36.
Nichols, B. A.
Normal rabbit alveolar macrophages. I. The phagocytosis of tubular myelin.
J. Exp. Med.
144:
906-919,
1976
37.
Ohmer-Schrock, D.,
C. Schlatterer,
H. Plattner,
and
J. Schlepper-Schaffer.
Interaction of lung surfactant protein A with alveolar macrophages.
Microsc. Res. Tech.
26:
374-380,
1993[Medline].
38.
Pison, U.,
J. R. Wright,
and
S. Hawgood.
Specific binding of surfactant apoprotein SP-A to rat alveolar macrophages.
Am. J. Physiol.
262 (Lung Cell. Mol. Physiol. 6):
L412-L417,
1992
39.
Prokhorova, S.,
N. Lavnikova,
and
D. L. Laskin.
Functional characterization of interstitial macrophages and subpopulations of alveolar macrophages from rat lung.
J. Leukoc. Biol.
55:
141-146,
1994[Abstract].
40.
Rice, W. R.,
G. F. Ross,
F. M. Singleton,
S. Kingle,
and
J. A. Whitsett.
Surfactant-associated protein inhibits phospholipid secretion from type II cells.
J. Appl. Physiol.
63:
692-698,
1987
41.
Sibille, Y.,
and
H. Y. Reynolds.
Macrophages and polymorphonuclear neutrophils in lung defense and injury.
Am. Rev. Respir. Dis.
141:
471-501,
1990[Medline].
42.
Territo, M. C.,
D. W. Golde,
and
M. J. Cline.
Macrophage activation and function.
In: Manual of Clinical Immunology, edited by N. R. Rose,
and H. Friedman. Washington, DC: Am. Soc. Microbiol., 1976, p. 142-147.
43.
Tsuzuki, A.,
Y. Kuroki,
and
T. Akino.
Pulmonary surfactant protein A-mediated uptake of phosphatidylcholine by alveolar type II cells.
Am. J. Physiol.
265 (Lung Cell. Mol. Physiol. 9):
L193-L199,
1993
44.
Viviano, C. J.,
W. E. Bakewell,
D. Dixon,
L. A. Dethloff,
and
G. E. R. Hook.
Altered regulation of surfactant phospholipid and protein A during acute pulmonary inflammation.
Biochim. Biophys. Acta
1259:
235-244,
1995[Medline].
45.
Walker, S. R.,
M. C. Williams,
and
B. Benson.
Immunocytochemical localization of the major surfactant apoproteins in type II cells, Clara cells, and alveolar macrophages of rat lungs.
J. Histochem. Cytochem.
34:
1137-1148,
1986[Abstract].
46.
Wizemann, T. M.,
and
D. L. Laskin.
Enhanced phagocytosis, chemotaxis, and production of reactive oxygen intermediates by interstitial lung macrophages following acute endotoxemia.
Am. J. Respir. Cell Mol. Biol.
11:
358-365,
1994[Abstract].
47.
Wright, J. R.,
R. E. Wager,
S. Hawgood,
L. Dobbs,
and
J. A. Clements.
Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of lipsomes by type II cells.
J. Biol. Chem.
262:
2888-2894,
1987
48.
Wright, J. R.,
and
D. C. Youmans.
Degradation of surfactant lipids and surfactant protein A by alveolar macrophages in vitro.
Am. J. Physiol.
268 (Lung Cell. Mol. Physiol. 12):
L772-L780,
1995
49.
Young, S. L.,
E. K. Fram,
E. Larson,
and
J. R. Wright.
Recycling of surfactant lipid and apoprotein A studied by electron microscopic autoradiography.
Am. J. Physiol.
265 (Lung Cell. Mol. Physiol. 9):
L19-L26,
1993
This article has been cited by other articles:
![]() |
C. Moulakakis and C. Stamme Role of clathrin-mediated endocytosis of surfactant protein A by alveolar macrophages in intracellular signaling Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L430 - L441. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Watford, M. B. Smithers, M. M. Frank, and J. R. Wright Surfactant protein A enhances the phagocytosis of C1q-coated particles by alveolar macrophages Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1011 - L1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Quintero, T. R. Korfhagen, and J. R. Wright Surfactant protein A regulates surfactant phospholipid clearance after LPS-induced injury in vivo Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L76 - L85. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |